Effects of colesevelam on insulin sensitivity in type 2 diabetes mellitus.
Phase of Trial: Phase II
Latest Information Update: 16 Aug 2017
At a glance
- Drugs Colesevelam (Primary) ; Insulin glargine
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- Sponsors Daiichi Sankyo Inc
- 31 Aug 2018 Biomarkers information updated
- 01 Jan 2012 Results published in Diabetes, Obesity and Metabolism.
- 01 Apr 2008 The expected completion date for this trial is now 1 Oct 2008, from clinicaltrials.gov record.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History